Eric Karas

SPRY

Eric Karas serves as officer: Chief Commercial Officer at ARS Pharmaceuticals, Inc. (SPRY). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

7 trades

$1.31M

Net Position

Net Seller

$1.31M

Companies Traded

SPRY

Active Period

Aug 2024 – Jun 2026

7 total trades

Most Recent

Sell SPRY

Jun 12, 2026 · $250.0K

Eric Karas's Insider Trading at ARS Pharmaceuticals, Inc. (SPRY)

Buys

0 · $0.00

Sells

7 · $1.31M

Total Shares Bought

Total Shares Sold

95,000

SPRY Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 12, 2026	Sell	25,000	$10.00	$250.0K	12,176
Jul 1, 2025	Sell	15,000	$16.99	$254.9K	0
Jun 18, 2025	Sell	15,000	$16.00	$240.0K	0
Mar 20, 2025	Sell	10,000	$14.00	$140.0K	0
Dec 4, 2024	Sell	10,000	$14.04	$140.4K	5,693
Sep 19, 2024	Sell	10,000	$14.00	$140.0K	5,693
Aug 21, 2024	Sell	10,000	$14.00	$140.0K	5,693

Related Insiders

Alexander A Fitzpatrick

officer: Chief Legal Officer

SPRYSell · Jun 12, 2026

Brian Dorsey

Chief Operating Officer

SPRYSell · Nov 13, 2025

Justin Chakma

Chief Business Officer

SPRYSell · Nov 12, 2025

Explore More Insider Trading Data

SPRY Insider Trading Activity

View all insider trades at ARS Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity